CNL

Cambridge Nutranostics Ltd. is collaborating with leading centers of medical science and technology to develop innovative point-of-care diagnostic tests. It has successfully transitioned the traditional laboratory-based oxygen-carrying capacity of lipoproteins (OCCL) test to a point-of-care model that is affordable and accessible to any healthcare practitioner, even untrained family members.